C Martin Harris Sells 360 Shares of Thermo Fisher Scientific Inc (NYSE:TMO) Stock

Thermo Fisher Scientific Inc (NYSE:TMO) Director C Martin Harris sold 360 shares of Thermo Fisher Scientific stock in a transaction on Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total transaction of $65,149.20. Following the completion of the sale, the director now owns 5,312 shares of the company’s stock, valued at approximately $961,312.64. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Thermo Fisher Scientific Inc (NYSE:TMO) traded up 0.082% on Friday, hitting $191.848. 732,226 shares of the company traded hands. Thermo Fisher Scientific Inc has a 1-year low of $139.07 and a 1-year high of $194.30. The firm has a market capitalization of $74.84 billion, a PE ratio of 33.423 and a beta of 1.05. The firm’s 50 day moving average price is $179.77 and its 200 day moving average price is $170.30.

Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The company had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.92 billion. During the same quarter last year, the firm earned $2.03 earnings per share. The firm’s quarterly revenue was up 10.2% compared to the same quarter last year. Equities research analysts predict that Thermo Fisher Scientific Inc will post $9.35 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 15th will be given a dividend of $0.15 per share. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $0.60 annualized dividend and a dividend yield of 0.31%. Thermo Fisher Scientific’s dividend payout ratio is currently 10.45%.

TRADEMARK VIOLATION WARNING: This piece was first published by BBNS and is the property of of BBNS. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this piece can be accessed at https://baseballnewssource.com/markets/c-martin-harris-sells-360-shares-of-thermo-fisher-scientific-inc-tmo-stock/1565285.html.

A number of analysts have commented on the stock. Zacks Investment Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research note on Tuesday. Cowen and Company reaffirmed an “outperform” rating and set a $220.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a report on Sunday, September 10th. Morgan Stanley reaffirmed an “overweight” rating and set a $220.00 price objective on shares of Thermo Fisher Scientific in a report on Wednesday, September 6th. Bank of America Corporation reaffirmed a “buy” rating and set a $210.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a report on Friday, July 21st. Finally, Barclays PLC reaffirmed an “overweight” rating and set a $200.00 price objective (up from $190.00) on shares of Thermo Fisher Scientific in a report on Monday, July 17th. One equities research analyst has rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. The company has an average rating of “Buy” and an average target price of $193.56.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Independent Portfolio Consultants Inc. boosted its holdings in Thermo Fisher Scientific by 0.3% in the first quarter. Independent Portfolio Consultants Inc. now owns 730 shares of the medical research company’s stock valued at $112,000 after purchasing an additional 2 shares during the period. Sharkey Howes & Javer boosted its holdings in Thermo Fisher Scientific by 1.0% in the first quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock valued at $113,000 after purchasing an additional 7 shares during the period. Beacon Trust Co. boosted its holdings in Thermo Fisher Scientific by 0.6% in the first quarter. Beacon Trust Co. now owns 2,159 shares of the medical research company’s stock valued at $341,000 after purchasing an additional 12 shares during the period. Dumont & Blake Investment Advisors LLC boosted its holdings in Thermo Fisher Scientific by 0.3% in the first quarter. Dumont & Blake Investment Advisors LLC now owns 5,526 shares of the medical research company’s stock valued at $849,000 after purchasing an additional 15 shares during the period. Finally, Reinhart Partners Inc. boosted its holdings in Thermo Fisher Scientific by 0.6% in the second quarter. Reinhart Partners Inc. now owns 3,430 shares of the medical research company’s stock valued at $598,000 after purchasing an additional 20 shares during the period. Institutional investors and hedge funds own 83.52% of the company’s stock.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Insider Buying and Selling by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with our FREE daily email newsletter.

 


Latest News

American League Once Again Dominates National League
American League Once Again Dominates National League
Los Angeles Dodgers Waiting But Magic Number Down to One
Los Angeles Dodgers Waiting But Magic Number Down to One
Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22


Leave a Reply

 
© 2006-2017 BBNS.